ZIM
VCYT icon

Zacks Investment Management’s Veracyte VCYT Stock Holding History

Zacks Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Sell
53,294
-2,842
-5% -$105K 0.01% 365
2025
Q4 		$2.36M Buy
56,136
+3,855
+7% +$155K 0.02% 324
2025
Q3 		$1.79M Buy
52,281
+3,595
+7% +$103K 0.01% 345
2025
Q2 		$1.32M Sell
48,686
-1,580
-3% -$45.8K 0.01% 370
2025
Q1 		$1.49M Buy
50,266
+668
+1% +$25.5K 0.01% 363
2024
Q4 		$1.96M Buy
49,598
+16,603
+50% +$629K 0.02% 341
2024
Q3 		$1.12M Buy
+32,995
New +$928K 0.01% 394

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Zacks Investment Management's VCYT Position: Q1 2026 in Review

Zacks Investment Management reduced its Veracyte (VCYT) stake by 5.1% in Q1 2026, selling an estimated $105K and leaving 53,294 shares worth $1.72M. The position accounts for 0.01% of the portfolio, ranked #365.

Zacks Investment Management first reported a position in VCYT in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.36M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Zacks Investment Management held 53,294 shares of Veracyte worth $1.72M as of Q1 2026.
  • Zacks Investment Management sold 2,842 Veracyte shares in Q1 2026, an estimated $105K.
  • Veracyte made up 0.01% of Zacks Investment Management's portfolio in Q1 2026, its #365 holding.
  • Zacks Investment Management first reported a position in Veracyte in Q3 2024 and has held it in 7 quarters since.
  • Zacks Investment Management's Veracyte position peaked at $2.36M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.